Polaryx Therapeutics, Inc., a clinical-stage biotechnology company, engages in the discovery, development, and commercialization of disease-modifying therapies for rare and pediatric lysosomal storage disorders in the United States. Its pipeline includes PLX-100, a preclinical stage orally administrable combination therapy; PLX-200, a repurposed oral small molecule for the treatment of LSDs; PLX-300, a preclinical stage orally administrable combination therapy; and PLX-400, a preclinical stage n...
Apr 23, 2026, 8:30 AM EDT - 20 days ago
2026-04-21T12:59:55.000Z - 21 days ago
Apr 21, 2026, 8:30 AM EDT - 22 days ago
Apr 15, 2026, 9:15 AM EDT - 27 days ago
Apr 1, 2026, 8:30 AM EDT - 6 weeks ago
2026-03-17T12:51:50.000Z - 2 months ago
Mar 17, 2026, 8:30 AM EDT - 2 months ago
2026-03-12T15:10:39.000Z - 2 months ago
2026-03-12T15:05:41.000Z - 2 months ago
Mar 12, 2026, 8:30 AM EDT - 2 months ago
2026-02-27T14:09:23.000Z - 2 months ago
2026-02-27T13:43:18.000Z - 2 months ago
Feb 27, 2026, 8:30 AM EST - 2 months ago
2026-02-27T13:15:01.000Z - 2 months ago
2026-02-17T13:35:43.000Z - 3 months ago
Feb 17, 2026, 8:30 AM EST - 3 months ago
2026-02-10T13:35:26.000Z - 3 months ago
Feb 10, 2026, 8:30 AM EST - 3 months ago
2026-02-06T15:20:14.000Z - 3 months ago
2026-02-06T15:10:13.000Z - 3 months ago
2026-02-05T20:35:14.000Z - 3 months ago
2026-02-05T20:30:16.000Z - 3 months ago
2026-02-05T13:45:44.000Z - 3 months ago
Feb 5, 2026, 8:30 AM EST - 3 months ago
2026-02-04T15:05:33.000Z - 3 months ago
2026-02-04T14:55:29.000Z - 3 months ago
2026-02-03T15:20:11.000Z - 3 months ago
2026-02-03T15:10:27.000Z - 3 months ago
2026-02-03T13:40:26.000Z - 3 months ago
Feb 3, 2026, 8:30 AM EST - 3 months ago
2026-02-02T13:51:16.000Z - 3 months ago
Feb 2, 2026, 8:30 AM EST - 3 months ago
Jan 30, 2026, 8:00 AM EST - 3 months ago